GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Total Payout Yield %

Psyence Biomedical (Psyence Biomedical) Total Payout Yield % : 0.00 (As of May. 16, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Psyence Biomedical's current Total Payout Yield % is 0.00%.


Psyence Biomedical Total Payout Yield % Historical Data

The historical data trend for Psyence Biomedical's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Total Payout Yield % Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Total Payout Yield %
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Total Payout Yield % - - -

Competitive Comparison of Psyence Biomedical's Total Payout Yield %

For the Biotechnology subindustry, Psyence Biomedical's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Total Payout Yield % falls into.



Psyence Biomedical Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Psyence Biomedical's Total Payout Yield % for the fiscal year that ended in Mar. 2023 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 0 + 0) / 0
=N/A%

Psyence Biomedical's annualized Total Payout Yield % for the quarter that ended in Mar. 2023 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 1 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Biomedical Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Psyence Biomedical Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines